Dr. Zhu Jingyi is an emerging researcher in vision science and ophthalmic biology, with a focused research profile encompassing retinal pathophysiology, neuroprotection, and molecular mechanisms of ocular diseases. The scholarly output comprises 8 research documents, which have received 89 citations from 87 citing publications, yielding an h-index of 6, reflecting growing academic impact. The research explores cellular and metabolic responses in glaucoma, retinal ischemia–reperfusion injury, and optic nerve damage, with particular emphasis on water transport regulation, ferroptosis, oxidative stress, and energy metabolism in retinal cells. Significant contributions include studies on AQP1-mediated lens physiology, DJ-1–saRNA–based nucleic acid delivery systems for retinal protection, and signaling pathways such as Rap1, YAP/TAZ, and Warburg-like glycolysis in retinal ganglion cell survival. This body of work advances mechanistic understanding and therapeutic strategies for degenerative and ischemic eye diseases.